Prognosis of acute severe autoimmune hepatitis (AS-AIH): The role of corticosteroids in modifying outcome

Journal of Hepatology

Volumn 61, Issue 4, 2014, Pages 876-882

  Yeoman, Andrew D ^a   Westbrook, Rachel H ^a   Zen, Yoh ^a   Bernal, William ^a   Al Chalabi, Thawab ^a   Wendon, Julia A ^a   O'Grady, John G ^a   Heneghan, Michael A ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Autoimmune hepatitis; Immunosuppression; Liver failure; Liver Transplantation

Indexed keywords

AZATHIOPRINE; HYDROCORTISONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; CORTICOSTEROID; GLUCOCORTICOID; IMMUNOLOGIC FACTOR;

ACUTE HEPATITIS; ACUTE LIVER FAILURE; ADULT; ARTICLE; AUTOIMMUNE HEPATITIS; BACTEREMIA; CLINICAL ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFECT; FEMALE; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERNATIONAL NORMALIZED RATIO; LIVER DYSFUNCTION; LIVER TRANSPLANTATION; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEPSIS; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE; ACUTE DISEASE; COMPLICATION; EARLY INTERVENTION; EPIDEMIOLOGY; HEPATITIS, AUTOIMMUNE; LIVER FUNCTION TEST; PATHOPHYSIOLOGY; PROCEDURES; SEROLOGY; SEVERITY OF ILLNESS INDEX; STATISTICS AND NUMERICAL DATA; UNITED KINGDOM;

ACUTE DISEASE; ADRENAL CORTEX HORMONES; ADULT; EARLY MEDICAL INTERVENTION; FEMALE; GLUCOCORTICOIDS; GREAT BRITAIN; HEPATIC ENCEPHALOPATHY; HEPATITIS, AUTOIMMUNE; HUMANS; IMMUNOLOGIC FACTORS; LIVER FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; SEPSIS; SEROLOGIC TESTS; SEVERITY OF ILLNESS INDEX;

EID: 84938926514     PISSN: 01688278     EISSN: 16000641     Source Type: Journal    
DOI: 10.1016/j.jhep.2014.06.030     Document Type: Editorial

References (25)

1. Kessler WR, Cummings OW, Eckert G, Chalasani N, Lumeng L, Kwo PY. Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis. Clin Gastroenterol Hepatol 2004; 2: 625-631.
2. Ferrari R, Pappas G, Agostinelli D, Muratori P, Muratori L, Lenzi M, et al. Type 1 autoimmune hepatitis: patterns of clinical presentation and differential diagnosis of the 'acute' type. QJM 2004; 97: 407-412.
3. Iwai M, Jo M, Ishii M, Mori T, Harada Y. Comparison of clinical features and liver histology in acute and chronic autoimmune hepatitis. Hepatol Res 2008; 38: 784-789.
4. Miyake Y, Iwasaki Y, Kobashi H, Yasunaka T, Ikeda F, Takaki A, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis 2010; 42: 51-54.
5. Lefkowitch JH, Apfelbaum TF, Weinberg L, Forester G. Acute liver biopsy lesions in early autoimmune ("lupoid") chronic active hepatitis. Liver 1984; 4: 379-386.
6. Alvarez F, Berg PA, Bianchi FB, Bianchi L, Burroughs AK, Cancado EL, et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999; 31: 929-938.
7. Hennes EM, Zeniya M, Czaja AJ, Pares A, Dalekos GN, Krawitt EL, et al. Simplified criteria for the diagnosis of autoimmune hepatitis. Hepatology 2008; 48: 169-176.
8. Ostapowicz G, Fontana RJ, Schiodt FV, Larson A, Davern TJ, Han SHB. Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med 2002; 137: 947-954.
9. Bernal W, Ma Y, Smith HM, Portmann B, Wendon J, Vergani D. The significance of autoantibodies and immunoglobulins in acute liver failure: a cohort study. J Hepatol 2007; 47: 664-670.
10. Takahashi H, Zeniya M. Acute presentation of autoimmune hepatitis: does it exist? A published work review. Hepatol Res 2011; 41: 498-504.
11. Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group criteria in acute-onset autoimmune hepatitis. Liver Int 2011; 31: 1013-1020.
12. Stravitz TR, Lefkowitch J, Fontana R, Gershwin M, Leung P, Sterling R, et al. Autoimmune acute liver failure: proposed clinical and histological criteria. Hepatology 2011; 53: 517-526.
13. Ichai P, Duclos-Vallee J-C, Guettier C, Hamida SB, Antonini T, Delvart V, et al. Usefulness of corticosteroids for the treatment of severe and fulminant forms of autoimmune hepatitis. Liver Transpl 2007; 13: 996-1003.
14. Miyake Y, Iwasaki Y, Terada R, Onishi T, Okamoto R, Sakai N, et al. Clinical characteristics of fulminant-type autoimmune hepatitis: an analysis of eleven cases. Aliment Pharmacol Ther 2006; 23: 1347-1353.
15. Verma S, Mahaeshwari A, Thuluvath P. Liver failure as initial presentation of autoimmune hepatitis: clinical characteristics, predictors of response to corticosteroid therapy, and outcomes. Hepatology 2009; 49: 1396-1397.
16. Yeoman AD, Westbrook RH, Al-Chalabi T, Carey I, Heaton ND, Portmann BC, et al. Diagnostic value and utility of the simplified International Autoimmune Hepatitis Group Criteria (IAIHG) in acute and chronic liver disease. Hepatology 2009; 50: 538-545.
17. Fujiwara K, Yasui S, Tawada A, Fukuda Y, Nakano M, Yokosuka O. Diagnostic value and utility of the simplified international autoimmune hepatitis group criteria in acute-onset autoimmune hepatitis. Liver Int 2011; 31: 1013-1020.
18. Al-Chalabi T, Underhill J, Portmann BC, McFarlane IG, Heneghan MA. Effects of serum aspartate transaminase levels in patients with autoimmune hepatitis influence disease course and outcome. Clin Gastroenterol Hepatol 2008; 6: 1389-1395.
19. Yeoman AD, Westbrook RH, Zen Y, Maninchedda P, Portmann BC, Devlin J, et al. Early predictors of corticosteroid treatment failure in icteric presentations of autoimmune hepatitis. Hepatology 2011; 53: 926-934.
20. Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology 2000; 31: 864-871.
21. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady JG, Burroughs A, et al. Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 2008; 57: 252-257.
22. Montano-Loza AJ, Carpenter HA, Czaja AJ. Features associated with treatment failure in type 1 autoimmune hepatitis and predictive value of the model of end-stage liver disease. Hepatology 2007; 46: 1138-1145.
23. Al-Chalabi T, Boccato S, Portmann BC, McFarlane IG, Heneghan MA. Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre. J Hepatol 2006; 45: 575-583.
24. Atterbury CE, Maddrey WC, Conn HO. Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled double blind clinical trial. Am J Dig Dis 1978; 23: 398-406.
25. O'Grady JG, Schalm SW, Williams R. Acute liver failure: redefining the syndromes. Lancet 1993; 342: 273-275.